Titre : Méticilline

Méticilline : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cluster Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Méticilline : Questions médicales les plus fréquentes", "headline": "Méticilline : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Méticilline : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-11", "dateModified": "2025-04-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Méticilline" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Pénicillines", "url": "https://questionsmedicales.fr/mesh/D010406", "about": { "@type": "MedicalCondition", "name": "Pénicillines", "code": { "@type": "MedicalCode", "code": "D010406", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.300.750" } } }, "about": { "@type": "MedicalCondition", "name": "Méticilline", "alternateName": "Methicillin", "code": { "@type": "MedicalCode", "code": "D008712", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Carmen Torres", "url": "https://questionsmedicales.fr/author/Carmen%20Torres", "affiliation": { "@type": "Organization", "name": "Area de Bioquímica y Biología Molecular, Universidad de La Rioja, Logroño, Spain." } }, { "@type": "Person", "name": "Eric S Donkor", "url": "https://questionsmedicales.fr/author/Eric%20S%20Donkor", "affiliation": { "@type": "Organization", "name": "1 Department of Medical Microbiology, University of Ghana, Accra, Ghana." } }, { "@type": "Person", "name": "Patrick Butaye", "url": "https://questionsmedicales.fr/author/Patrick%20Butaye", "affiliation": { "@type": "Organization", "name": "School of Veterinary Medicine, Ross University, West Farm 000265, Saint Kitts and Nevis." } }, { "@type": "Person", "name": "Assia Mairi", "url": "https://questionsmedicales.fr/author/Assia%20Mairi", "affiliation": { "@type": "Organization", "name": "Laboratoire d'Ecologie Microbienne, FSNV, Université de Bejaia, Bejaia 06000, Algeria." } }, { "@type": "Person", "name": "Abdelaziz Touati", "url": "https://questionsmedicales.fr/author/Abdelaziz%20Touati", "affiliation": { "@type": "Organization", "name": "Laboratoire d'Ecologie Microbienne, FSNV, Université de Bejaia, Bejaia 06000, Algeria." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programme.", "datePublished": "2023-06-30", "url": "https://questionsmedicales.fr/article/37389544", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.55563/clinexprheumatol/f5r0oe" } }, { "@type": "ScholarlyArticle", "name": "The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach.", "datePublished": "2023-06-20", "url": "https://questionsmedicales.fr/article/37338613", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00415-023-11827-7" } }, { "@type": "ScholarlyArticle", "name": "Improving community health worker treatment for malaria, diarrhoea, and pneumonia in Uganda through inSCALE community and mHealth innovations: A cluster randomised controlled trial.", "datePublished": "2023-06-12", "url": "https://questionsmedicales.fr/article/37307519", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pdig.0000217" } }, { "@type": "ScholarlyArticle", "name": "Evaluating an audit and feedback intervention for reducing overuse of pathology test requesting by Australian general practitioners: protocol for a factorial cluster randomised controlled trial.", "datePublished": "2023-05-17", "url": "https://questionsmedicales.fr/article/37197811", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2023-072248" } }, { "@type": "ScholarlyArticle", "name": "Thematic Foreword from the Guest Editor to the Special Issue Entitled \"The Role of Interactions in Complexes, Clusters and Crystal Structures-Theoretical Analyses and Experimental Evidences\".", "datePublished": "2023-04-03", "url": "https://questionsmedicales.fr/article/37047653", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms24076680" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "bêta-Lactames", "item": "https://questionsmedicales.fr/mesh/D047090" }, { "@type": "ListItem", "position": 6, "name": "Pénicillines", "item": "https://questionsmedicales.fr/mesh/D010406" }, { "@type": "ListItem", "position": 7, "name": "Méticilline", "item": "https://questionsmedicales.fr/mesh/D008712" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Méticilline - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Méticilline", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Méticilline", "description": "Comment diagnostiquer une infection résistante à la méticilline ?\nQuels tests sont utilisés pour détecter la résistance à la méticilline ?\nQuels symptômes indiquent une infection à staphylocoque ?\nQuand faut-il suspecter une infection à SARM ?\nQuel rôle joue la culture de sang dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Cluster+Analysis&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Méticilline", "description": "Quels sont les symptômes d'une infection à SARM ?\nComment se manifeste une infection cutanée ?\nQuels signes indiquent une infection systémique ?\nLes infections à méticilline provoquent-elles des douleurs ?\nQuels symptômes nécessitent une consultation urgente ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Cluster+Analysis&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Méticilline", "description": "Comment prévenir les infections à SARM ?\nLes antibiotiques préventifs sont-ils efficaces ?\nQuel rôle joue la vaccination dans la prévention ?\nComment éviter la propagation en milieu hospitalier ?\nLes soins des plaies aident-ils à prévenir les infections ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Cluster+Analysis&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Méticilline", "description": "Quel est le traitement principal des infections à SARM ?\nComment traiter une infection cutanée causée par SARM ?\nLes antibiotiques oraux sont-ils efficaces contre SARM ?\nQuelle est l'importance de l'antibiogramme ?\nPeut-on utiliser la méticilline pour traiter le SARM ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Cluster+Analysis&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Méticilline", "description": "Quelles sont les complications possibles d'une infection à SARM ?\nComment une infection à SARM peut-elle affecter le cœur ?\nLes infections à SARM peuvent-elles causer des lésions pulmonaires ?\nQuels risques pour les patients diabétiques ?\nLes infections à SARM peuvent-elles être fatales ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Cluster+Analysis&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Méticilline", "description": "Quels sont les principaux facteurs de risque pour SARM ?\nLe partage d'objets personnels augmente-t-il le risque ?\nLes athlètes sont-ils plus à risque d'infection à SARM ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes patients en soins intensifs sont-ils à risque ?", "url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=Cluster+Analysis&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection résistante à la méticilline ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des cultures bactériennes et des tests de sensibilité aux antibiotiques sont effectués." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter la résistance à la méticilline ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Le test de diffusion sur gélose et le test d'agar de dilution sont couramment utilisés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection à staphylocoque ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, rougeur, gonflement et douleur au site d'infection sont des signes courants." } }, { "@type": "Question", "name": "Quand faut-il suspecter une infection à SARM ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "En cas d'infections cutanées récurrentes ou de non-réponse aux antibiotiques classiques." } }, { "@type": "Question", "name": "Quel rôle joue la culture de sang dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'identifier la présence de bactéries dans le sang et leur sensibilité." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection à SARM ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des rougeurs, des douleurs, des abcès et parfois de la fièvre." } }, { "@type": "Question", "name": "Comment se manifeste une infection cutanée ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des rougeurs, des gonflements, de la chaleur et des douleurs." } }, { "@type": "Question", "name": "Quels signes indiquent une infection systémique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre élevée, frissons, fatigue extrême et confusion peuvent indiquer une infection grave." } }, { "@type": "Question", "name": "Les infections à méticilline provoquent-elles des douleurs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections peuvent causer des douleurs localisées ou généralisées selon la gravité." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une consultation urgente ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme une fièvre élevée, des difficultés respiratoires ou des éruptions cutanées graves." } }, { "@type": "Question", "name": "Comment prévenir les infections à SARM ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Pratiquer une bonne hygiène, se laver les mains et éviter le partage d'objets personnels." } }, { "@type": "Question", "name": "Les antibiotiques préventifs sont-ils efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation d'antibiotiques préventifs n'est généralement pas recommandée sans indication." } }, { "@type": "Question", "name": "Quel rôle joue la vaccination dans la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccin spécifique contre le SARM, mais la vaccination générale aide." } }, { "@type": "Question", "name": "Comment éviter la propagation en milieu hospitalier ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des protocoles stricts d'hygiène et d'isolement des patients infectés sont essentiels." } }, { "@type": "Question", "name": "Les soins des plaies aident-ils à prévenir les infections ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon soin des plaies réduit le risque d'infection par des bactéries résistantes." } }, { "@type": "Question", "name": "Quel est le traitement principal des infections à SARM ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les infections à SARM sont généralement traitées avec des antibiotiques comme la vancomycine." } }, { "@type": "Question", "name": "Comment traiter une infection cutanée causée par SARM ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des antibiotiques et parfois un drainage chirurgical des abcès." } }, { "@type": "Question", "name": "Les antibiotiques oraux sont-ils efficaces contre SARM ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains antibiotiques oraux comme la clindamycine peuvent être efficaces selon la sensibilité." } }, { "@type": "Question", "name": "Quelle est l'importance de l'antibiogramme ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'antibiogramme détermine la sensibilité des bactéries aux antibiotiques, guidant le traitement." } }, { "@type": "Question", "name": "Peut-on utiliser la méticilline pour traiter le SARM ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, le SARM est résistant à la méticilline et nécessite d'autres antibiotiques." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une infection à SARM ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections profondes, des septicémies et des infections osseuses." } }, { "@type": "Question", "name": "Comment une infection à SARM peut-elle affecter le cœur ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer une endocardite, une infection des valves cardiaques, potentiellement mortelle." } }, { "@type": "Question", "name": "Les infections à SARM peuvent-elles causer des lésions pulmonaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des pneumonies, surtout chez les patients immunodéprimés." } }, { "@type": "Question", "name": "Quels risques pour les patients diabétiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les patients diabétiques sont plus susceptibles de développer des infections graves à SARM." } }, { "@type": "Question", "name": "Les infections à SARM peuvent-elles être fatales ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être mortelles, surtout si elles ne sont pas traitées rapidement et correctement." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour SARM ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hospitalisation, les interventions chirurgicales et l'immunodépression." } }, { "@type": "Question", "name": "Le partage d'objets personnels augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le partage d'objets comme les serviettes ou les rasoirs peut favoriser la transmission." } }, { "@type": "Question", "name": "Les athlètes sont-ils plus à risque d'infection à SARM ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en raison des contacts physiques fréquents et des blessures cutanées potentielles." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles ont un système immunitaire affaibli, ce qui augmente le risque d'infections." } }, { "@type": "Question", "name": "Les patients en soins intensifs sont-ils à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en raison de leur état de santé fragile et de l'exposition à des bactéries résistantes." } } ] } ] }

Sources (10000 au total)

Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programme.

Sjögren's syndrome (SS) is an autoimmune disease with an impact on quality of life (QoL). The aim of patient education (PE) is to improve patients' QoL. The main objective of this study was to describ... A self-administered questionnaire was proposed to 408 patients with SS followed in the internal medicine department of the University Hospital of Lille, France with the aim of assessing the six sphere... 127 patients (31%) agreed to participate and were included in the study; 96% were women and the median age was 51 years (± 14.5). They mostly reported dry syndrome and fatigue. They had a good knowled... Our study described an SS population in terms of the different spheres of an allosteric model applicable to the practice of PE. A cluster of patients appeared to present more impact of the disease and...

The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach.

Upper motor neuron (UMN) and lower motor neuron (LMN) involvement represent the core clinical features of amyotrophic lateral sclerosis (ALS). Several studies divided patients into prevalent UMN and L... This study aimed to investigate whether patients spontaneously segregate based on the extent of UMN and LMN involvement without a-priori categorization and to identify potential clinical and prognosti... Eighty-eight consecutive spinal-onset ALS patients were referred to an ALS tertiary center between 2015 and 2022. UMN and LMN burden was assessed with the Penn Upper Motor Neuron scale (PUMNS) and the... Three distinct clusters emerged at cluster analysis. Patients in "cluster-1" showed moderate UMN and severe LMN involvement, corresponding to the typical ALS phenotype. Patients in "cluster-2" showed ... Spinal-onset ALS can be categorized into three groups according to LMN and UMN burden. The UMN burden is related to higher diagnostic certainty and broader disease spread, while LMN involvement is ass...

Evaluating an audit and feedback intervention for reducing overuse of pathology test requesting by Australian general practitioners: protocol for a factorial cluster randomised controlled trial.

Consistent evidence shows pathology services are overused worldwide and that about one-third of testing is unnecessary. Audit and feedback (AF) is effective for improving care but few trials evaluatin... This is a factorial cluster randomised trial conducted in Australian general practice. It uses routinely collected Medicare Benefits Schedule data to identify the study population, apply eligibility c... Ethics approval was received from the Bond University Human Research Ethics Committee (#JH03507; approved 30 November 2021). The results of this study will be published in a peer-reviewed journal and ... ACTRN12622000566730....

Bridging gaps across levels of care in rehabilitation of patients with rheumatic and musculoskeletal diseases: Results from a stepped-wedge cluster randomized controlled trial.

To compare the effectiveness of a structured goal-setting and tailored follow-up rehabilitation intervention with existing rehabilitation in patients with rheumatic and musculoskeletal diseases.... A pragmatic stepped-wedge cluster randomized trial.... Eight rehabilitation centers in secondary healthcare, Norway.... A total of 374 adults with rheumatic and musculoskeletal diseases were included in either the experimental (168) or the control group (206).... A new rehabilitation intervention which comprised structured goal setting, action planning, motivational interviewing, digital self-monitoring of goal progress, and individual follow-up support after ... Patient-reported outcomes were collected electronically on admission and discharge from rehabilitation, and after 2, 7, and 12 months. The primary outcome was patients' goal attainment measured by the... No significant treatment effects of the BRIDGE-intervention were found for either primary (Patient Specific Functional Scale mean difference 0.1 [95% CI: -0.5, 0.8],... The BRIDGE-intervention was not shown to be more effective than existing rehabilitation for patients with rheumatic and musculoskeletal diseases. There is still a need for more knowledge about factors...

Dynamics in the expression of programmed death ligand 1 and cluster of differentiation 163 in the tumor microenvironment of uterine cervical cancer: a single-center retrospective study.

Radiotherapy (RT) destroys cancer cells and activates the immune system while suppressing the immunity of tumor-associated tissues, including the tumor microenvironment (TME). However, to date, no ant... Twenty-six patients who had completed radical RT for cervical cancer were categorized into the following two groups according to whether the cancer recurred and/or metastasized within 2 years after th... The expression levels of PD-L1 and CD163 in the TME in the treatment success group were lower than those in the treatment failure group at the midpoint during brachytherapy (p < 0.01 and p = 0.08, res... The expression rates of CD163 and PD-L1 in the TME during brachytherapy were related to treatment response and the 2-year PFS. This study may increase our understanding of tumor-associated immunity in...

A study protocol for a cluster randomized controlled trial to test the applicability of the South African diabetes prevention program in the Eastern Cape Province of South Africa.

Convincing evidence supports the effectiveness of lifestyle interventions in preventing the occurrence of diabetes in high-income countries, however little is known about appropriate interventions for... The SA-DPP, which is an cluster randomized control trial, will be implemented in adults aged 30-65 years residing in the OR Tambo district, Eastern Cape, SA. Participants will be recruited using self-... The SA-DPP could represent a successful model for the prevention of diabetes and potentially other lifestyle-related diseases in SA and other countries in the region that are confronted with similar c... PACTR202205591282906....

Barber-Led HIV/Sexually Transmitted Infection Risk Reduction for Young African-American Men: Efficacy and Mediation in a Cluster Randomized Controlled Trial.

The aim of this study is to evaluate the efficacy and mediation of a culturally appropriate, theory-based HIV/STI (sexually transmitted infection) risk-reduction intervention delivered in barbershops ... In a cluster randomized controlled trial, 24 matched pairs of barbershops serving African-American men ages 18-24 in the 10 Philadelphia, PA zip codes with the highest HIV/AIDS prevalence were randomi... Participants were 618 men, 319 in the HIV/STI intervention and 299 in the control intervention. Generalized estimating equation analysis indicated that the direct effect of the HIV/STI intervention in... Sexual risks among young African-American men can be reduced by barber-led theory-based, culturally appropriate HIV/STI risk-reduction interventions in barbershops in high HIV prevalence neighborhoods...

A pilot cluster randomised controlled trial of a peer-delivered outreach community-based smoking cessation intervention for women living in disadvantaged communities in Ireland.

The health of women in rural communities is adversely impacted by increased rates of tobacco use linked to socio-economic disadvantage (SED) and by limited access to services. We Can Quit (WCQ) is a s... The We Can Quit2 (WCQ2) pilot cluster randomised controlled trial with an inbuilt process evaluation was conducted in four matched pairs of urban and semi-rural SED districts (8-10,000 women per distr... Findings showed that that the WCQ outreach programme is acceptable and feasible to implement for smoking women living in disadvantaged neighbourhoods. A secondary outcome of smoking abstinence (self-r... The design of our project provides an affordable solution for governments in prioritising outreach smoking cessation in vulnerable populations in countries with rising rates of female lung cancer. Our...